These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


224 related items for PubMed ID: 1779452

  • 1. [Evaluation of clinical usefulness of a rapid quantitative measurement of D dimer (cross-linked fibrin degradation products)].
    Takahashi H, Wada K, Takizawa S, Sakurai G, Hanano M, Niwano H, Tatewaki W, Shibata A.
    Rinsho Ketsueki; 1991 Dec; 32(12):1533-9. PubMed ID: 1779452
    [Abstract] [Full Text] [Related]

  • 2. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
    Takahashi H, Tatewaki W, Wada K, Niwano H, Shibata A.
    Thromb Haemost; 1990 Jun 28; 63(3):340-4. PubMed ID: 2402738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT, Francis CW.
    Semin Thromb Hemost; 2001 Dec 28; 27(6):657-66. PubMed ID: 11740689
    [Abstract] [Full Text] [Related]

  • 5. Fibrin D-dimer in thrombogenic disorders.
    Matsuo T, Kobayashi H, Kario K, Suzuki S.
    Semin Thromb Hemost; 2000 Dec 28; 26(1):101-7. PubMed ID: 10805290
    [Abstract] [Full Text] [Related]

  • 6. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 28; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 7. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S.
    Rinsho Byori; 2004 Apr 28; 52(4):355-61. PubMed ID: 15164605
    [Abstract] [Full Text] [Related]

  • 8. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
    Gando S, Hayakawa M, Sawamura A, Hoshino H, Oshiro A, Kubota N, Jesmin S.
    Thromb Res; 2007 Apr 28; 121(1):67-73. PubMed ID: 17397908
    [Abstract] [Full Text] [Related]

  • 9. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F, Hasegawa N, Asano K, Sayama K, Fujita H, Urano T, Aoki T, Ishizaka A, Kanazawa M, Kawashiro T.
    Kokyu To Junkan; 1992 Jul 28; 40(7):685-90. PubMed ID: 1387724
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
    Okajima K, Uchiba M, Murakami K, Okabe H, Takatsuki K.
    Am J Hematol; 1996 Mar 28; 51(3):186-91. PubMed ID: 8619398
    [Abstract] [Full Text] [Related]

  • 12. [Clinical usefulness of the measurement of plasma D-dimer levels].
    Suehiro A, Koyama T.
    Rinsho Byori; 1991 Jul 28; 39(7):694-700. PubMed ID: 1920861
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
    Wada H, Sakuragawa N, Shiku H.
    Semin Thromb Hemost; 1998 Jul 28; 24(3):293-7. PubMed ID: 9701463
    [Abstract] [Full Text] [Related]

  • 15. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
    Okumura N, Matsuzawa A, Terasawa F, Kameko M, Sasaki Y, Nakagoshi R, Ishikawa S, Hashikura Y, Matsunami H, Kawasaki S.
    Rinsho Byori; 1995 Mar 28; 43(3):269-74. PubMed ID: 7745833
    [Abstract] [Full Text] [Related]

  • 16. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation].
    Fukuda C, Iijima K, Nakamura K.
    Rinsho Byori; 1996 Aug 28; 44(8):750-6. PubMed ID: 8816061
    [Abstract] [Full Text] [Related]

  • 17. Postoperative hypercoagulable state followed by hyperfibrinolysis related to wound healing after hepatic resection.
    Tsuji K, Eguchi Y, Kodama M.
    J Am Coll Surg; 1996 Sep 28; 183(3):230-8. PubMed ID: 8784316
    [Abstract] [Full Text] [Related]

  • 18. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK, Mestries JC, Gascon MP, Ythier A.
    Thromb Haemost; 1997 May 28; 77(5):905-10. PubMed ID: 9184401
    [Abstract] [Full Text] [Related]

  • 19. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis].
    Imoto K, Yasumuro Y, Taki M, Suzuki N, Tanabe H, Ichikawa Y.
    Rinsho Byori; 2001 Mar 28; 49(3):283-9. PubMed ID: 11307330
    [Abstract] [Full Text] [Related]

  • 20. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
    Wada H, Wakita Y, Nakase T, Shimura M, Hiyoyama K, Nagaya S, Deguchi H, Mori Y, Kaneko T, Deguchi K, Fujii J, Shiku H.
    Am J Hematol; 1996 Apr 28; 51(4):255-60. PubMed ID: 8602623
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.